News

Past, present and future of aflibercept are discussed

The rare disease multisystemic smooth muscle dysfunction syndrome has a serious outcome

Lenticule extraction found effective for patients with myopia and myopic astigmatism

Study identifies factors for discontinuing Lucentis treatment and helps streamline AMD services

Multifocal IOL for patients who have 'distant-dominant lifestyles' and wish to remain spectacle-free

Cataract a common characteristic in both forms of the disease

Combination cataract/micro-bypass stent shows excellent efficacy and safety profile

Study results demonstrate lower IOP achievable with 360-degree versus 180-degree SLT

SLT/Med study finds SLT effective and safe as first-line therapy in OAG or OHT

A round-up of the latest ophthalmic products

Reviewing highlights of 2012 and looking forward to 2013

Indocyanine green angiography (ICGA) correlate with OCT findings of polypoidal lesions in polypoidal choroidal vasculopathy.

Piggybacking with the Add-On IOL is safe, efficient and reliable for correcting pseudophakic refractive errors.

Ranibizumab injections could cause geographic atrophy (GA) progression in eyes with choroidal neovascularisation (CNV).

Alcon will acquire the ophthalmic division of SensoMotoric Instruments (SMI).

Intravitreal anti-VEGF monotherapy is safe and effective in treatment-naïve subretinal neovascular membrane (SRNVM) secondary to macular telangiectasia (Mactel).

Axial length/refractive status affects the peripapillary retinal nerve fibre layer (RNFL) thickness profile in eyes measured by RTVue OCT.

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

Bausch + Lomb will purchase all outstanding shares of leading ophthalmic laser company Technolas Perfect Vision.

Multiple micro-bypass stents with concurrent cataract surgery lowers IOP to less than 15 mmHg in patients with open-angle glaucoma (OAG) and cataract.

The IOL master is more accurate than A-scan immersion biometry in silicone oil (SO)-filled eyes.

The Royal College of General Practitioners (RCGP) has announced that ageing and sight loss is one of its four clinical priorities for the years 2013 to 2016.

Six eye charities have joined forces to invest £90 000 into six eye research projects.

The UK Vision Strategy consultation is due to close on 16 November 2012.

Phacoemulsification is linked to a higher rate of posterior capsule rupture in vitrectomized eyes, compared to combined vitrectomy and cataract surgery.

Timolol is successful in treating myopic regression after LASIK and lasts for at least six months.

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

Repetitive probing with intranasal endoscopic imaging provides information about congenital nasolacrimal duct obstructions.

Understanding the differences

Ophthalmology Futures 2012 European Forum